- Duration: 2 Days
The purpose of this symposium is to update medical practitioners in the greater Midwest region on the future of cardiac electrophysiology and on new diagnosis and treatment guidelines in the care and management of patients with atrial fibrillation, ventricular arrhythmias and heart failure. Participants will learn about advances in atrial fibrillation ablation techniques. A review of clinical trials that have helped change the clinical practice of EP will be held. Participants in this symposium will examine the latest trends in Left Atrial Appendage exclusion and gain a greater understanding of anticoagulation and stoke prophylaxis. An examination of arrhythmia and device therapies that affect congenital heart disease patients will be discussed.
To learn more and register for this event, please click on the "register now" button below.
The Sheraton Kansas City Hotel at Crown Center, Kansas City, MO, USA
Dhanunjaya Lakkireddy, MD, FACC, FHRS
- Demonstrate an understanding of anticoagulation and stoke prophylaxis
- Discuss advances in atrial fibrillation ablation
- Review emerging trends in VT ablation and how it affects patients' long term outcomes
- Examine the latest trends in Left Atrial Appendage exclusion
- Discuss device malfunctions, lead failure, and other device related issues
- Examine arrhythmia and device therapy in congenital heart disease
- Discuss the newest types of devices including subcutaneous and MRI compatible devices
- Examine the role of genetics in patients with arrhythmias
Physicians, Advance Practice Registered Nurses, Nurses, Allied Health and other Health Care Professionals in the fields of Electrophysiology, Cardiology, and Family and Internal Medicine.
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.